The mechanism by which pop-1 mediates this effect remains unclear, with further work warranted to elucidate the precise role of the TCF7L2/pop-1 homolog in rescuing hyperglycemia-induced toxicity by PARP-1 inhibition. The gene discussed is TCF7L2; the disease is Hyperglycemia.